Viewing Study NCT00411034


Ignite Creation Date: 2025-12-25 @ 2:29 AM
Ignite Modification Date: 2026-02-09 @ 9:49 AM
Study NCT ID: NCT00411034
Status: COMPLETED
Last Update Posted: 2010-04-27
First Post: 2006-12-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Repeated-Dose Evaluation of Use of a Pain Relieving Drug and Safety of OROS Hydromorphone HCI in Patients With Chronic Cancer Pain
Sponsor: Alza Corporation, DE, USA
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Analgesics, Opioid View
None Pain View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Opioids View
None Chronic Cancer Pain View
None analgesic View